The stacked bar graph compares the business activity of a pharmaceutical company across three regions, namely Asia, Europe, and America, in terms of total revenue earned, between 2002 and 2006.
Overall, there were decreases in the proportion of total sales of this firm in America and Europe, while the opposite was true for that of the branch in Asia. Additionally, the division in America generated the highest share of total revenue initially, but this was the case for the branch in Asia in the final year.
In America, the company accounted for 41% of total sales in 2002, the highest among the three areas, followed by a decline by nearly half to the bottom of 27% in 2004, before recovering steadily to 30% in 2006.
Meanwhile, 34% of total sales were made in the European market in the first year, before gradually rising and peaking at 38% in 2004, outnumbering the two other regions’ figures. Subsequently, however, the total sales saw a slight downward trend, ending at America’s final level.
Finally, the total sales rate of the company’s branch in Asia earned only 25% initially, after which it experienced a steady increase over the next 4 years, peaking at 40% in 2006, surpassing the two other regions to dominate this year.